Articles
Why COVID-19 could Potentially Boost Oligonucleotide Synthesis Market Growth?
by Pramod Kumar Digital Marketing ProfessionalThe most-prominent factors leading to the growth of
the oligonucleotide synthesis market are the technological advancements in the
field, increasing government support, rising number of research studies related
to synthetic biology, and surging incidence of infections and cancer. As a
result, the worth of the sales of synthesized oligonucleotides will increase
from $1.5 billion in 2017 to $2.8
billion by 2023, at a 10.8% CAGR during the forecast period
(2018–2023). Oligonucleotides are short chains of ribonucleic acid (RNA) and
deoxyribonucleic acid (DNA), which have wide-ranging medical research and
clinical applications.
Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample
Equipment, reagents & consumables, and synthesized
oligonucleotides are the categories when the market is segmented on the basis
of offering. Among these, the synthesized oligonucleotides category dominated
the market during 2013–2017 (historical period), and it is also expected to
grow the fastest during the forecast period. Due to the rising demand for such
biologics for research and clinical applications, biotechnology and
biopharmaceutical companies are outsourcing their production to contract
manufacturers, as this way, the bigger companies can offer a high quantity of
products at a lower operational cost.
Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=oligonucleotide-synthesis-market
The key driver for the oligonucleotide synthesis
market is the advancements in the field that have allowed for faster and
cost-effective synthesis of such products. Some of these technological
improvements are new sets of protective amino groups, microchips, high-throughput
synthesizers, and better coupling reagents. In addition, with the introduction
of the microarray technology, many oligonucleotide conjugates with biological
ligands have been created, which are now being used for the diagnosis of
inherited diseases. Additionally, the error rate has come down owing to the
enhancements in enzymatic error correction technologies.
Thus, with continued technological advancements,
more-effective oligonucleotides would emerge, which could potentially revolutionize
healthcare.
Sponsor Ads
About Pramod Kumar 
Digital Marketing Professional
89 connections, 2 recommendations, 268 honor points.Joined APSense since, July 17th, 2017, From Ave, United States.
Created on Jul 22nd 2021 05:52. Viewed 186 times.
